Capital Fund Management S.A. Pacific Biosciences Of California, Inc. Put Options Transaction History

Capital Fund Management S.A.

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$3.52 - $9.59 $246,752 - $672,259	-70,100 Reduced 47.98%	76,000 $285,000
Q4 2023 Feb 14, 2024	BUY	$5.97 - $10.36 $407,154 - $706,552	68,200 Added 87.55%	146,100 $1.43 Million
Q3 2023 Nov 14, 2023	BUY	$8.23 - $13.93 $366,235 - $619,885	44,500 Added 133.23%	77,900 $650,000
Q2 2023 Aug 14, 2023	SELL	$9.97 - $14.05 $212,361 - $299,265	-21,300 Reduced 38.94%	33,400 $444,000
Q1 2023 May 15, 2023	BUY	$7.94 - $12.02 $434,318 - $657,494	54,700 New	54,700 $633,000
Q1 2022 May 12, 2022	SELL	$8.43 - $20.9 $127,293 - $315,590	-15,100 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$19.26 - $30.08 $157,932 - $246,656	-8,200 Reduced 35.19%	15,100 $308,000
Q3 2021 Nov 12, 2021	SELL	$24.86 - $35.02 $213,796 - $301,172	-8,600 Reduced 26.96%	23,300 $595,000
Q2 2021 Aug 12, 2021	BUY	$22.3 - $36.02 $430,390 - $695,186	19,300 Added 153.17%	31,900 $1.12 Million
Q1 2021 May 14, 2021	BUY	$26.38 - $51.15 $332,388 - $644,490	12,600 New	12,600 $419,000

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.